đ WELCOME TO THE PREMIERE OF DIMENSION ZERO LIVE!
Join award-winning screenwriter Danny Alex for the very first live episode of Dimension Zero, where science, science fiction, physics, astronomy, and popular culture collide.
Tonight weâll introduce the vision behind the channel and explore some of the biggest questions in science fiction and the real science behind them.
Tonightâs topics include: âą Star Trek. âą Battlestar Galactica. âą Supergirl. âą The Odyssey. âą Antimatter. âą Physics vs. Science Fiction. âą Space Exploration. âą Audience Q&A and more!
If youâve ever wondered whether warp drives, antimatter reactors, faster-than-light travel, artificial intelligence, or the incredible technologies of science fiction could ever become reality, this is the show for you.
Dimension Zero explores The Science of Science Fiction, separating scientific fact from fiction while celebrating the worlds we love.
đĄ Future Business Tech analyzes the AI, capital, and frontier-tech decisions shaping the next decade, and explores the civilizational futures they build toward.
Creatures evolution never designed. Come geek out inside The Giantâs Shoulder Community. Ad Free exclusive content and much more â https://www.skool.com/the-giants-shouâŠ
Michael Levinâs lab takes ordinary frog skin cells and lets them reassemble into beings that have never existed in the history of life â xenobots â and then a version with a core of neurons: neurobots. With no evolutionary history as a \.
Artificial intelligence has achieved remarkable breakthroughs in recent years, from generating human-like text and images to solving complex scientific and engineering problems. Yet some challenges remain extraordinarily difficult even for the most advanced AI systems. This has fueled growing interest in quantum computing, a technology that processes information in fundamentally different ways from classical computers. Researchers are now exploring whether quantum algorithms can tackle certain optimization, simulation, and computational problems that push conventional AI systems to their limits. Recent experiments and research papers have generated excitement by demonstrating situations where quantum approaches may offer unique advantages, reigniting debate about how these two revolutionary technologies could work together in the future.
Rather than viewing quantum computing and AI as competitors, many experts believe they could become powerful partners. Quantum processors may eventually help accelerate specific machine learning tasks, improve complex simulations, and solve optimization problems that are critical to industries such as logistics, finance, materials science, and drug discovery. At the same time, scientists caution that practical large-scale quantum computing remains an active area of research, and many headline-grabbing claims require careful scrutiny and independent verification. Even so, the rapid progress in both fields suggests that the future of computing may be shaped not by AI alone, but by a combination of artificial intelligence and quantum technologies working together to tackle problems once thought impossible.
Disclaimer.
This video is intended for educational and informational purposes only. Quantum computing and artificial intelligence are rapidly evolving fields, and interpretations of research findings may change as new evidence becomes available. The content presented is based on publicly available studies, expert analysis, and current technological developments.
Like \& Subscribe.
If you enjoyed this video, please Like, Share, and Subscribe for more quantum computing news, AI breakthroughs, technology analysis, and future-tech insights.
A Yale-led research team has developed the first standalone device that produces the liquid fuel methanol using only sunlight, water, and carbon dioxide as the ingredients.
The artificial âleaf,â like its namesake in nature, is a chemistry marvel. It brings the scientific mimicry of photosynthesis â the process of converting sunlight and water into chemical energy â to a new level, converting sunlight to methanol 32 times more efficiently than the previous conversion record for artificial leaf technologies that generate alcohol products.
The first global safety regulations for fully autonomous vehicles were adopted at the U.N., setting uniform international requirements that could pave the way for larger-scale rollouts. The framework is expected to enter into force in January 2027.
The first global regulations for fully autonomous vehicles were adopted Wednesday, a U.N. agency said, establishing uniform international safety requirements that could pave the way for larger-scale rollouts of self-driving cars.
Safety concerns and the cost of developing next-level systems have long slowed progress on autonomous vehicles.
As self-driving cars have begun to hit the road in a growing number of cities, fragmented national approaches to regulation have spurred manufacturer fears that vehicles developed for one market could be blocked from others.
Disclaimer: Do NOT attempt without proper medical supervision.
In a paradigm-shifting breakthrough, Phase III clinical trials of DT120 â a novel, pharmaceutical-grade formulation of LSD â have demonstrated unprecedented efficacy in treating Major Depressive Disorder (MDD) following just a single dose. The study, encompassing 149 patients, revealed that a one-time administration of DT120 significantly outperformed a placebo, achieving the trialâs primary endpoint by reducing MADRS depression scores by an 8-point margin at six weeks. Remarkably, patients experienced rapid therapeutic relief within just one week, showcasing a massive 14-point advantage over the placebo group. Unlike conventional daily antidepressants that often take weeks to manifest effects, DT120 delivers profound and sustained symptom reduction from a single intervention. Hailed by Definium Therapeuticsâ CEO Rob Burrow as a potential âbest-in-classâ therapy, these groundbreaking findings not only pave the way for expedited regulatory approval but also underscore the transformative potential of psychedelics to fundamentally revolutionize modern mental health care.
Definium Therapeutics has announced strong results in a phase 3 trial of its single-dosed lysergide (LSD) drug DT120 in treating adults with major depressive disorder (MDD), meeting its primary goal and all key secondary efficacy endpoints in the first trial of its kind.
The results come from the Emerge trial, a randomized, double-blind, placebo-controlled study featuring 149 participants aged 18 to 74 years enrolled across 20 sites. The participants all met specific MDD measures. They needed to have a DSM-5-confirmed diagnosis of MDD, a Montgomery-Ă sberg Depression Rating Scale (MADRS) score of at least 26 and a Clinical Global ImpressionâSeverity (CGI-S) score of at least 4 at screening and baseline.
The study examined the effectiveness of a single 100 ”g dose of DT120 ODT compared with a placebo in alleviating MDD symptoms. In 2023, we covered an earlier trial of lysergide, which had shown positive results in treating general anxiety disorder (GAD).
Multiferroics are materials that exhibit more than one prominent âferroicâ property, such as ferromagnetism and ferroelectricity. One of their most advantageous features is that they allow engineers to control their magnetic states with electric fields or vice versa, due to an effect known as magnetoelectric coupling.
Computing ecosystems are changing dramatically. AI, quantum computing, exascale supercomputers, biological DNA, chemical and neuromorphic technologies will change the world.
